Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy

American Journal of Psychiatry

Volumn 159, Issue 4, 2002, Pages 630-636

  Kumar, Anand ^a   Thomas, Albert ^a   Lavretsky, Helen ^a   Yue, Kenneth ^a   Huda, Amir ^a   Curran, John ^a   Venkatraman, Talaignair ^a   Estanol, Laverne ^a   Mintz, Jim ^a   Mega, Michael ^a   Toga, Arthur ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BRAIN LEVEL; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; FRONTAL LOBE; GRAY MATTER; HUMAN; IMAGING SYSTEM; MALE; ONSET AGE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

AGED; ASPARTIC ACID; CHOLINE; CREATINE; DEPRESSIVE DISORDER, MAJOR; DOMINANCE, CEREBRAL; ENERGY METABOLISM; FEMALE; FRONTAL LOBE; GYRUS CINGULI; HUMANS; INOSITOL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; REFERENCE VALUES;

EID: 0036218889     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.159.4.630     Document Type: Article

References (46)

1. The epidemiology of depression in an elderly community population
2. Depressive symptoms and the cost of health services in HMO patients aged 65 years and older: A 4-year prospective study
3. On the inseparability of mental and physical health in aged persons: Lessons from depression and medical comorbidity
4. Diagnosis and treatment of depression in late life
5. Regional cerebral glucose metabolism in late-life depression and Alzheimer disease: A preliminary positron emission tomography study
6. Regional cerebral blood flow in mood disorders, II: Comparison of major depression and Alzheimer's disease
7. Neuroanatomic substrates of depression in the elderly
8. Hippocampal atrophy in recurrent major depression
9. Atrophy and high intensity lesions: Complementary neurobiological mechanisms in late-life major depression
10. Quantitative cerebral anatomy in depression: A controlled magnetic resonance imaging study
11. Late-onset minor and major depression: Early evidence for common neuroanatomical substrates detected by using MRI
12. Neuropsychological studies of the frontal lobes
13. Circuitry of primate prefrontal cortex and regulation of behavior by representational memory
14. Development of a rating scale for primary depressive illness
15. "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician
16. Localized high-resolution proton NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivo
17. Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy
18. In vivo proton spectroscopy in presence of eddy currents
19. Estimation of metabolite concentrations from localized in vivo proton NMR spectra
20. MRI-PET registration with automated algorithm
21. A nonparametric method for automatic correction of intensity nonuniformity in MRI data
22. Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder
23. Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders
24. Magnetic resonance spectroscopy in affective disorders
25. Basal ganglia choline levels in depression and response to fluoxetine treatment: An in vivo proton magnetic resonance spectroscopy study
26. Brain choline in depression: In vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy
27. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline
28. Clinical tools for the 90s: Magnetic resonance spectroscopy and metabolite imaging
29. A cholinergic-adrenergic hypothesis of mania and depression
30. Biochemical considerations in 1H spectroscopy: Glutamate and glutamine; myo-inositol and related metabolites
31. Cerebral 1H MR spectroscopy and neuropsychologic status of patients with hepatic encephalopathy
32. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy
33. Localized 1H NMR spectroscopy in patients with chronic hepatic encephalopathy: Analysis of changes in cerebral glutamine, choline and inositols
34. Relative concentrations of proton MR visible neurochemicals in gray and white matter in human brain
35. In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: Effects of normal aging
36. High spatial resolution 1 H-MRSI and segmented MRI of cortical gray matter and subcortical white matter in three regions of the human brain
37. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS
38. Differentiation of metabolic concentrations between gray matter and white matter of human brain by in vivo 1H magnetic resonance spectroscopy
39. Localized proton NMR spectroscopy in different regions of the human brain in vivo: Relaxation times and concentrations of cerebral metabolites
40. Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease
41. A 1H MRS study of probable Alzheimer's disease and normal aging: Implications for longitudinal monitoring of dementia progression
42. GLIA: Listening and talking to the synapse
43. Localized two-dimensional shift correlated MR spectroscopy of human brain
44. 2D MR spectroscopic characterization of NAA, glutamate and glutathione in human brain in vivo